Cambridge Raman Imaging Ltd. (CRIL), was registered in the UK in 2018. Our focus is on bringing to market high speed, label-free Raman imaging instruments. Our first application is in medical imaging, delivering better patient outcomes through faster and more accurate tumour diagnosis and treatment.
The company is supported by co-founder Frontier IP Group Plc. a company dedicated to the commercialisation of new technology. Frontier IP provides ‘hands-on’ leadership to support CRIL as well as developing the business strategy and raising funding. Together the founders have built a team of dedicated scientists forming an extensive knowledge base in the field of ultra-fast lasers, Coherent Raman Spectroscopy and imaging.
CRIL is forming a subsidiary in Italy and raising funding to cover the cost of building a working prototype CRS microscope for medical imaging. A letter of intent for financial support of a manufacturing facility has been issued by the region of Basilicata in Italy (http://www.regione.basilicata.it/giunta/site/Giunta/detail.jsp?otype=1012&id=3050407&value=regione) which we hope to conclude within the coming months. A leading medical imaging company with microscopes in over 1000 hospitals is offering an equity investment and negotiating for licensing rights. By April 2020 the company will have a laboratory based proof of concept and a pilot facility capable of assembling CRS microscopes in small quantities for validation trials.
Our focus is on bringing to market better patient outcomes through faster and more accurate tumour diagnosis and treatment.